Companies /Healthcare

Bristol-Myers Squibb Company

NYSE: BMY Drug Manufacturers - General
$63.06
▲ $0.22 (+0.35%) today
Markets closed · 11:38am ET

BMY Coverage

Page 38
4:01am ET
Health and Healthcare

The Next Blockbuster Drugs: A $170 Billion Opportunity

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market. With help…

Douglas A. McIntyre
9:36pm ET
Investing

Imagine That: An IPO Coming This Week (BMY, MJN)

If you can believe it, there is an initial public offering on deck this week. Bristol-Myers Squibb Co. (NYSE: BMY) is set to partially spin off Mead Johnson Nutrition (NYSE: MJN). It…

BMY
Douglas A. McIntyre